South Korea · Delayed Price · Currency is KRW Kwang Dong Pharmaceutical Statistics
Total Valuation
KRX:009290 has a market cap or net worth of KRW 310.87 billion. The enterprise value is 442.61 billion.
| Market Cap | 310.87B |
| Enterprise Value | 442.61B |
Important Dates
The next estimated earnings date is Friday, May 15, 2026.
| Earnings Date | May 15, 2026 |
| Ex-Dividend Date | Mar 31, 2026 |
Share Statistics
KRX:009290 has 36.66 million shares outstanding. The number of shares has increased by 0.52% in one year.
| Current Share Class | 36.66M |
| Shares Outstanding | 36.66M |
| Shares Change (YoY) | +0.52% |
| Shares Change (QoQ) | +9.84% |
| Owned by Insiders (%) | 13.96% |
| Owned by Institutions (%) | 27.41% |
| Float | 29.51M |
Valuation Ratios
The trailing PE ratio is 16.28.
| PE Ratio | 16.28 |
| Forward PE | n/a |
| PS Ratio | 0.19 |
| PB Ratio | 0.44 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | 5.92 |
| P/OCF Ratio | 3.78 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.75, with an EV/FCF ratio of 8.43.
| EV / Earnings | 21.11 |
| EV / Sales | 0.27 |
| EV / EBITDA | 11.75 |
| EV / EBIT | 22.58 |
| EV / FCF | 8.43 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.43.
| Current Ratio | 1.36 |
| Quick Ratio | 0.96 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 6.18 |
| Debt / FCF | 5.78 |
| Interest Coverage | 2.82 |
Financial Efficiency
Return on equity (ROE) is 3.21% and return on invested capital (ROIC) is 2.86%.
| Return on Equity (ROE) | 3.21% |
| Return on Assets (ROA) | 1.56% |
| Return on Invested Capital (ROIC) | 2.86% |
| Return on Capital Employed (ROCE) | 3.91% |
| Weighted Average Cost of Capital (WACC) | 4.83% |
| Revenue Per Employee | 1.63B |
| Profits Per Employee | 20.54M |
| Employee Count | 1,021 |
| Asset Turnover | 1.33 |
| Inventory Turnover | 6.47 |
Taxes
In the past 12 months, KRX:009290 has paid 9.66 billion in taxes.
| Income Tax | 9.66B |
| Effective Tax Rate | 31.16% |
Stock Price Statistics
The stock price has increased by +57.87% in the last 52 weeks. The beta is 0.52, so KRX:009290's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +57.87% |
| 50-Day Moving Average | 8,291.00 |
| 200-Day Moving Average | 6,556.80 |
| Relative Strength Index (RSI) | 50.02 |
| Average Volume (20 Days) | 305,035 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:009290 had revenue of KRW 1.66 trillion and earned 20.97 billion in profits. Earnings per share was 521.00.
| Revenue | 1.66T |
| Gross Profit | 298.95B |
| Operating Income | 31.05B |
| Pretax Income | 30.98B |
| Net Income | 20.97B |
| EBITDA | 49.10B |
| EBIT | 31.05B |
| Earnings Per Share (EPS) | 521.00 |
Balance Sheet
The company has 227.69 billion in cash and 303.21 billion in debt, with a net cash position of -75.52 billion or -2,059.98 per share.
| Cash & Cash Equivalents | 227.69B |
| Total Debt | 303.21B |
| Net Cash | -75.52B |
| Net Cash Per Share | -2,059.98 |
| Equity (Book Value) | 711.80B |
| Book Value Per Share | 15,195.02 |
| Working Capital | 191.71B |
Cash Flow
In the last 12 months, operating cash flow was 82.34 billion and capital expenditures -29.86 billion, giving a free cash flow of 52.48 billion.
| Operating Cash Flow | 82.34B |
| Capital Expenditures | -29.86B |
| Depreciation & Amortization | 18.06B |
| Net Borrowing | -11.84B |
| Free Cash Flow | 52.48B |
| FCF Per Share | 1,431.52 |
Margins
Gross margin is 18.01%, with operating and profit margins of 1.87% and 1.26%.
| Gross Margin | 18.01% |
| Operating Margin | 1.87% |
| Pretax Margin | 1.87% |
| Profit Margin | 1.26% |
| EBITDA Margin | 2.96% |
| EBIT Margin | 1.87% |
| FCF Margin | 3.16% |
Dividends & Yields
This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 1.18%.
| Dividend Per Share | 100.00 |
| Dividend Yield | 1.18% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 18.73% |
| Buyback Yield | -0.52% |
| Shareholder Yield | 0.68% |
| Earnings Yield | 6.75% |
| FCF Yield | 16.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 26, 1999. It was a forward split with a ratio of 5.
| Last Split Date | Apr 26, 1999 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
KRX:009290 has an Altman Z-Score of 2.31 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.31 |
| Piotroski F-Score | 5 |